Aytu Biopharma Inc AYTU:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/03/24 EDT
3.01UNCH (UNCH)
Volume
21,145
52 week range
1.38 - 3.50
Loading...
  • Open2.96
  • Day High3.04
  • Day Low2.92
  • Prev Close3.01
  • 52 Week High3.50
  • 52 Week High Date10/18/23
  • 52 Week Low1.38
  • 52 Week Low Date06/29/23

Key Stats

  • Market Cap16.758M
  • Shares Out5.57M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-1.37
  • YTD % Change5.99

KEY STATS

  • Open2.96
  • Day High3.04
  • Day Low2.92
  • Prev Close3.01
  • 52 Week High3.50
  • 52 Week High Date10/18/23
  • 52 Week Low1.38
  • 52 Week Low Date06/29/23
  • Market Cap16.758M
  • Shares Out5.57M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-1.37
  • YTD % Change5.99

RATIOS/PROFITABILITY

  • EPS (TTM)-4.06
  • P/E (TTM)-0.74
  • Fwd P/E (NTM)-4.30
  • EBITDA (TTM)4.495M
  • ROE (TTM)-45.75%
  • Revenue (TTM)98.498M
  • Gross Margin (TTM)63.24%
  • Net Margin (TTM)-18.27%
  • Debt To Equity (MRQ)48.83%

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aytu Biopharma Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Aytu BioPharma, Inc. is a pharmaceutical company commercializing a portfolio of commercial prescription therapeutics and consumer health products. The Company’s Rx segment consists of prescription pharmaceutical products and the Consumer Health segment consists of various consumer healthcare products (the Consumer Health Portfolio). The Company’s prescription products include Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets and Cotempla XR-ODT...
Joshua Disbrow
Chairman of the Board, Chief Executive Officer
Mark Oki
Chief Financial Officer, Treasurer, Company Secretary
Address
7900 E. Union Avenue, Suite 920
Denver, CO
80237
United States

Top Peers

SYMBOLLASTCHG%CHG
MEIP
MEI Pharma Inc
3.06UNCHUNCH
ACORQ
Acorda Therapeutics Inc
0.85UNCHUNCH
SCYX
SCYNEXIS Inc
1.77-0.01-0.56%
OPTN
OptiNose Inc
1.01+0.13+15.09%
CPIX
Cumberland Pharmaceuticals Inc
1.58+0.07+4.64%